NOT FOR DISTRIBUTION
Header cover image

Market Cap

CA$211.3m

Last Updated

2021/05/15 23:43 UTC

Data Sources

Company Financials +

Executive Summary

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. More Details


Snowflake Analysis

High growth potential with excellent balance sheet.

Share Price & News

How has Opsens's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: OPS is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: OPS's weekly volatility (9%) has been stable over the past year.


Market Performance


7 Day Return

-12.0%

OPS

-11.2%

CA Medical Equipment

-0.7%

CA Market


1 Year Return

235.6%

OPS

25.0%

CA Medical Equipment

39.3%

CA Market

Return vs Industry: OPS exceeded the Canadian Medical Equipment industry which returned 25.5% over the past year.

Return vs Market: OPS exceeded the Canadian Market which returned 39.2% over the past year.


Shareholder returns

OPSIndustryMarket
7 Day-12.0%-11.2%-0.7%
30 Day9.4%-13.5%1.0%
90 Day4.8%-28.2%6.1%
1 Year235.6%235.6%25.0%25.0%43.8%39.3%
3 Year110.6%110.6%-60.5%-60.5%28.6%16.4%
5 Year41.4%41.4%79.5%79.5%58.6%34.7%

Long-Term Price Volatility Vs. Market

How volatile is Opsens's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Opsens undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: OPS (CA$1.98) is trading below our estimate of fair value (CA$6.47)

Significantly Below Fair Value: OPS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: OPS is poor value based on its PE Ratio (144x) compared to the North American Medical Equipment industry average (58.3x).

PE vs Market: OPS is poor value based on its PE Ratio (144x) compared to the Canadian market (15x).


Price to Earnings Growth Ratio

PEG Ratio: OPS is poor value based on its PEG Ratio (2.4x)


Price to Book Ratio

PB vs Industry: OPS's PB Ratio (4.9x) is in line with the CA Medical Equipment industry average.


Future Growth

How is Opsens forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?

59.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: OPS's forecast earnings growth (59.8% per year) is above the savings rate (1.5%).

Earnings vs Market: OPS's earnings (59.8% per year) are forecast to grow faster than the Canadian market (13.4% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: OPS's revenue (28.6% per year) is forecast to grow faster than the Canadian market (6.3% per year).

High Growth Revenue: OPS's revenue (28.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if OPS's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Opsens performed over the past 5 years?

32.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: OPS has a large one-off gain of CA$2.3M impacting its February 28 2021 financial results.

Growing Profit Margin: OPS became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: OPS has become profitable over the past 5 years, growing earnings by 32.6% per year.

Accelerating Growth: OPS has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: OPS has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (16.2%).


Return on Equity

High ROE: OPS's Return on Equity (2.9%) is considered low.


Financial Health

How is Opsens's financial position?


Financial Position Analysis

Short Term Liabilities: OPS's short term assets (CA$51.2M) exceed its short term liabilities (CA$7.1M).

Long Term Liabilities: OPS's short term assets (CA$51.2M) exceed its long term liabilities (CA$10.4M).


Debt to Equity History and Analysis

Debt Level: OPS's debt to equity ratio (20.3%) is considered satisfactory.

Reducing Debt: OPS's debt to equity ratio has reduced from 48.3% to 20.3% over the past 5 years.

Debt Coverage: OPS's debt is well covered by operating cash flow (37.6%).

Interest Coverage: Insufficient data to determine if OPS's interest payments on its debt are well covered by EBIT.


Balance Sheet


Dividend

What is Opsens's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate OPS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OPS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if OPS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OPS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of OPS's dividend in 3 years as they are not forecast to pay a notable one for the Canadian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.3yrs

Average board tenure


CEO

Louis Laflamme

8.33yrs

Tenure

CA$341,907

Compensation

Mr. Louis Laflamme, C.A, C.P.A., has been the Chief Executive Officer and President of Opsens Inc. since January 7, 2013. Mr. Laflamme’s primary mandate is to see to the operational management of the Corpo...


CEO Compensation Analysis

Compensation vs Market: Louis's total compensation ($USD282.49K) is below average for companies of similar size in the Canadian market ($USD471.71K).

Compensation vs Earnings: Louis's compensation has been consistent with company performance over the past year.


Board Members

Experienced Board: OPS's board of directors are considered experienced (6.3 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 18.2%.


Top Shareholders

Company Information

Opsens Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Opsens Inc.
  • Ticker: OPS
  • Exchange: TSX
  • Founded: NaN
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: CA$211.289m
  • Shares outstanding: 106.71m
  • Website: https://opsens.com

Number of Employees


Location

  • Opsens Inc.
  • 750 Boulevard du Parc-Technologique
  • Québec
  • Quebec
  • G1P 4S3
  • Canada

Listings


Biography

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for interventional cardiology, fractional flow reserve (FFR), oil and gas, and industrial applications. The company operates in t...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/15 23:43
End of Day Share Price2021/05/14 00:00
Earnings2021/02/28
Annual Earnings2020/08/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.